about
Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of cancer and liver diseases. Its initial focus is on the development of small-molecule inhibitors of gale...
Read More
30.84
2.67
(9.48%)
14,031
XNAS Volume
XNAS 22 Jan, 2026 11:54 AM (EST)
Not Eligible
Expensive Valuation
Technically Bullish
Galecto Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..